Itafos Bilan de santé

Santé financière contrôle des critères 5/6

Itafos possède un total de capitaux propres de $318.2M et une dette totale de $100.9M, ce qui porte son ratio d'endettement à 31.7%. Son actif total et son passif total sont $666.5M et de $348.2M. L'EBIT de Itafos est $106.0M ce qui fait que son ratio de couverture des intérêts 16.7. Elle dispose de liquidités et de placements à court terme de $65.3M.

Informations clés

31.7%

Ratio d'endettement

US$100.89m

Dette

Ratio de couverture des intérêts	16.7x
Argent liquide	US$65.29m
Fonds propres	US$318.25m
Total du passif	US$348.24m
Total des actifs	US$666.48m

Mises à jour récentes de la santé financière

Recent updates

Investors Can Find Comfort In Itafos' (CVE:IFOS) Earnings Quality

Nov 14

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Oct 10

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Mar 29

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Nov 10

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Sep 16

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Aug 02

Is Itafos (CVE:IFOS) Using Too Much Debt?

Feb 03

Is Itafos (CVE:IFOS) Using Too Much Debt?

Sep 08

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

May 11

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

Aug 25

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Apr 12

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Feb 18

Can You Imagine How Elated Itafos' (CVE:IFOS) Shareholders Feel About Its 743% Share Price Gain?

Dec 17

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de IFOS ( $249.0M ) dépassent ses passifs à court terme ( $93.6M ).

Passif à long terme: Les actifs à court terme de IFOS ( $249.0M ) ne couvrent pas ses passifs à long terme ( $254.6M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de IFOS ( 11.2% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de IFOS a été réduit de 89.8% à 31.7% au cours des 5 dernières années.

Couverture de la dette: La dette de IFOS est bien couverte par le flux de trésorerie opérationnel ( 112.7% ).

Couverture des intérêts: Les paiements d'intérêts de IFOS sur sa dette sont bien couverts par l'EBIT ( 16.7 x couverture).

Itafos Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Is Itafos (CVE:IFOS) Using Too Much Debt?

Is Itafos (CVE:IFOS) Using Too Much Debt?

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

Recent updates

Investors Can Find Comfort In Itafos' (CVE:IFOS) Earnings Quality

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Maintains Operating Guidance for the Year 2024

Niobium Dragon Pty Ltd entered into a binding Share Sale Agreement to acquire Itafos Arraias Mineração e Fertilizantes S.A. from Itafos Inc. (TSXV:IFOS) ) for $14.9 million.

Itafos Inc. Announces Elena Viyella De Paliza Did Not Stand for Re-Election as Director

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Announces Results of Updated Itafos Conda Technical Report

Itafos Inc., Annual General Meeting, Jun 19, 2024

Itafos' (CVE:IFOS) Soft Earnings Are Actually Better Than They Appear

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CEO & Director exercised options to buy CA$84k worth of stock.

Third quarter 2023 earnings released: EPS: US$0.016 (vs US$0.043 in 3Q 2022)

Itafos Inc. Narrows its Earnings Guidance for 2023

Little Excitement Around Itafos Inc.'s (CVE:IFOS) Earnings

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

Itafos (CVE:IFOS) Knows How To Allocate Capital Effectively

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Provides Earnings Guidance for the Year 2023

Does Itafos (CVE:IFOS) Have A Healthy Balance Sheet?

Itafos Files Updated Feasibility Study for the Farim Phosphate Project

Itafos Inc. Completes Updated Feasibility Study for the Farim Phosphate Project

Consensus EPS estimates increase by 16%

Itafos Inc., Annual General Meeting, Jul 13, 2023

First quarter 2023 earnings released: EPS: US$0.15 (vs US$0.18 in 1Q 2022)

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 22%

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 26%

Price target decreased to CA$5.25

Itafos Inc. Provides Earnings Guidance for Fiscal Year 2022

Price target decreased to CA$5.25

Investor sentiment deteriorated over the past week

Is Itafos (CVE:IFOS) Using Too Much Debt?

Investor sentiment improved over the past week

Consensus EPS estimates increase by 17%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Itafos Inc. Appoints Matthew O’Neill as Chief Financial Officer Succeeding George Burdette

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Itafos Inc. Announces Production and Sales of Hydrofluorosilicic Acid at Conda

Investor sentiment improved over the past week

Itafos Inc. Provides Earnings Guidance for the First Half and Second Half of 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

These 4 Measures Indicate That Itafos (CVE:IFOS) Is Using Debt Extensively

Less than half of directors are independent

Itafos Inc., Annual General Meeting, Jun 24, 2022

Itafos Inc. Announces Board Changes

Itafos Inc. Announces Resumption of Sulfuric Acid Production at Arraias

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS US$0.05 (vs US$0.11 loss in 2Q 2020)

Health Check: How Prudently Does Itafos (CVE:IFOS) Use Debt?

First quarter 2021 earnings released: EPS US$0.01 (vs US$0.10 loss in 1Q 2020)

Is Itafos (CVE:IFOS) Using Debt In A Risky Way?

Full year 2020 earnings released: US$0.34 loss per share (vs US$1.02 loss in FY 2019)

This Analyst Just Made A Massive Upgrade To Their Itafos (CVE:IFOS) Earnings Forecasts

Itafos Appoints David Brush as Chief Strategy Officer

Itafos(TSXV:IFOS) dropped from S&P/TSX Venture Composite Index

New 90-day high: CA$0.52